Prognostic Comparison between Oncotype DX(®) and a 23-Gene Classifier, RecurIndex(®), on the Taiwan Breast Cancer Population

The applicability of the Oncotype DX(®) (Genomic Health, Inc., Redwood City, CA, USA) recurrence score (RS) in Asian populations is unclear. A 23-gene classifier, RecurIndex(®) (Amwise Diagnostics, Pte. Ltd., Singapore), has been developed based on the gene expression profiles of early-stage breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Chuan-Hsun, Yang, Po-Sheng, Hsieh, Chia-Ming, Chen, Ting-Hao, Cheng, Skye Hung-Chun, Yang, Cheng-En, Huang, Chiun-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689820/
https://www.ncbi.nlm.nih.gov/pubmed/36428912
http://dx.doi.org/10.3390/diagnostics12112850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689820/
https://www.ncbi.nlm.nih.gov/pubmed/36428912
http://dx.doi.org/10.3390/diagnostics12112850

Ejemplares similares